Akoya Biosciences Inc at Morgan Stanley Global Healthcare Conference Transcript
Good morning, everyone. Thanks for joining us. My name is Tejas Savant, I'm the life science tools and diagnostics analyst at Morgan Stanley. It's my pleasure this morning to host Akoya, and from the company, we have Brian, Niro and Joe. So thanks, gentlemen, for doing this. Appreciate it. Before we kick it off, quickly need to rattle off the disclosures here, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, do reach out to your sales rep. So with that, Brian, thanks again. Before we get into the meat and bones of the discussion, can you just take a couple of minutes to just briefly recap the story where Akoya fits into the spatial biology landscape? And what are you most proud of over the last 12 months?
Great. Well, thanks again for having us. We really do appreciate it. maybe just to pull back a little bit. It's pretty -- it's been really
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |